|
"ann lii cheng"的相關文件
顯示項目 596-605 / 690 (共69頁)
<< < 55 56 57 58 59 60 61 62 63 64 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T09:42:02Z |
Erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)
|
Hsu, C.;Shen, Y.-C.;Cheng, C.-C.;Cheng, A.-L.;Hu, F.-C.;Yeh, K.-H.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:41:59Z |
No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply
|
Kuo, S.-H. and Weng, W.-H. and Yeh, K.-H. and Chen, L.-T. and Cheng, A.-L.; Sung-Hsin Kuo; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:41:58Z |
Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse
|
Sung-Hsin Kuo and Hui-Jen Tsai and Wen-Hui Weng and Chi-Cheng Li and Kun-Huei Yeh and Li-Tzong Chen and Ann-Lii Cheng; Kuo, Sung-Hsin;Tsai, Hui-Jen;Weng, Wen-Hui;Li, Chi-Cheng;Yeh, Kun-Huei;Chen, Li-Tzong;Cheng, Ann-Lii; 郭頌鑫;鄭安理;葉坤輝; Kuo, Sung-Hsin; Sung-Hsin Kuo; Tsai, Hui-Jen; KUN-HUEI YEH; Weng, Wen-Hui; ANN-LII CHENG; Li, Chi-Cheng; Yeh, Kun-Huei; Chen, Li-Tzong; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T09:41:56Z |
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
|
Chen, Wei-Wu;Chang, Dwan-Ying;Huang, Shu-Min;Lin, Ching-Hung;Hsu, Chun;Lin, Ming-Hwai;Huang, Chiun-Shen;Lu, Yen-Shen;Cheng, Ann-Lii; Chen, Wei-Wu; Chang, Dwan-Ying; Huang, Shu-Min; Lin, Ching-Hung; Hsu, Chun; Lin, Ming-Hwai; Huang, Chiun-Shen; Lu, Yen-Shen; Cheng, Ann-Lii; CHING-HUNG LIN; ANN-LII CHENG; Hsu, Chun; ���T�� |
| 臺大學術典藏 |
2018-09-10T09:41:56Z |
CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer
|
Kuo, Sung-Hsin; Yang, Shi-Yi; Lien, Huang-Chun; Lo, Chiao; Lin, Ching-Hung; Lu, Yen-Sen; Cheng, Ann-Lii; Chang, King-Jeng; Huang, Chiun-Sheng; Kuo, Sung-Hsin; CHIUN-SHENG HUANG; Sung-Hsin Kuo; Lien, Huang-Chun; CHING-HUNG LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:41:56Z |
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation
|
Lin, Ching-Hung;Liu, Jacqueline M.;Lu, Yen-Shen;Lan, Chieh;Lee, Wei-Chung;Kuo, Kuan-Ting;Wang, Chung-Chieh;Chang, Dwan-Ying;Huang, Chiun-Sheng;Cheng, Ann-Lii; Lin, Ching-Hung;Liu, Jacqueline M.;Lu, Yen-Shen;Lan, Chieh;Lee, Wei-Chung;Kuo, Kuan-Ting;Wang, Chung-Chieh;Chang, Dwan-Ying;Huang, Chiun-Sheng;Cheng, Ann-Lii; Wang, Chung-Chieh; Chang, Dwan-Ying; Huang, Chiun-Sheng; Cheng, Ann-Lii; 盧彥伸 ;郭冠廷 ;王中傑 ;鄭安理 ;黃俊升 ;張端瑩 ;林璟宏; CHIUN-SHENG HUANG; Lin, Ching-Hung; Liu, Jacqueline M.; CHING-HUNG LIN; KUAN-TING KUO; Lu, Yen-Shen; Kuo, Kuan-Ting; ANN-LII CHENG; Lan, Chieh; Lee, Wei-Chung |
| 臺大學術典藏 |
2018-09-10T09:41:56Z |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen;林季宏; Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen; Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen; 盧彥伸;林璟宏;詹一秀;陳怡君;鄭安理;林季宏; I-SHIOW JAN; Kao, Jia-Horng; Chen, I-Chun; Lin, Ching-Hung; CHING-HUNG LIN; Lin, Ching-Hung; ANN-LII CHENG; Jan, I-Shiow; Jan, I-Shiow; Cheng, Ann-Lii; Cheng, Ann-Lii; Lu, Yen-Shen; Lu, Yen-Shen; 高嘉宏 |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen, K.-F.;Chen, H.-L.;Shiau, C.-W.;Liu, C.-Y.;Chu, P.-Y.;Tai, W.-T.;Ichikawa, K.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:39:53Z |
Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome
|
Yu, H.-C.;Hou, D.-R.;Liu, C.-Y.;Lin, C.-S.;Shiau, C.-W.;Cheng, A.-L.;Chen, K.-F.; Yu, H.-C.; Hou, D.-R.; Liu, C.-Y.; Lin, C.-S.; Shiau, C.-W.; Cheng, A.-L.; Chen, K.-F.; CHEN-SI LIN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:39:53Z |
Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma
|
Yu, H.-C.;Chen, H.-J.;Chang, Y.-L.;Liu, C.-Y.;Shiau, C.-W.;Cheng, A.-L.;Chen, K.-F.; Kuen-Feng Chen; ANN-LII CHENG |
顯示項目 596-605 / 690 (共69頁)
<< < 55 56 57 58 59 60 61 62 63 64 > >>
每頁顯示[10|25|50]項目
|
